CLOV vs RAPT · rev $1.37B vs $132.1M cap
Clover Health Investments Corp (CLOV) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
CLOV currently screens at market cap $1.55B. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the CLOV and RAPT stock pages for the full models.
Not investment advice.